BackNorthView Acquisition - Tradeable Rights - Aug 2027 Overview

NorthView Acquisition - Tradeable Rights - Aug 2027 Total Liabilities

Latest total liabilities for NVACR: $29M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$29.06M
103.23% YoYΔ $14.76M vs prior year quarter

Peer average

Loading

NorthView Acquisition - Tradeable Rights - Aug 2027 Total Liabilities History

Loading

NorthView Acquisition - Tradeable Rights - Aug 2027 vs. peers: Total Liabilities Comparison

Loading

NorthView Acquisition - Tradeable Rights - Aug 2027 Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

NorthView Acquisition - Tradeable Rights - Aug 2027 (NVACR) FAQ

The latest total liabilities for NVACR is $29M as of March 2026. That compares with $14M in the prior-year period — up 103.2% year over year. Investors often review this figure alongside NorthView Acquisition - Tradeable Rights - Aug 2027's historical trend and sector peers before judging valuation or financial health.

Over the past year, NVACR's total liabilities moved from $14M to $29M — a 103.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NorthView Acquisition - Tradeable Rights - Aug 2027's operating scale or balance-sheet position.

A total liabilities figure of $29M for NVACR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NVACR's total liabilities ($29M), review year-over-year change from $14M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.